People

Chris Yook is a senior associate in the Antitrust practice of King & Spalding. He advises clients on the antitrust implications of strategic business decisions, including securing approvals for cross border mergers and acquisitions. Chris also represents clients in government enforcement actions and complex civil litigation, including some of the largest class actions. He has been named a “Rising Star” for antitrust litigation in Washington SuperLawyers from 2016 through 2019.

His recent matters include securing one of the first dismissals of a corporate defendant in the In re Generic Pharmaceuticals Pricing Antitrust Litigation. Chris also holds leadership roles in bar associations, including serving as a Young Lawyer Representative for the ABA Section of Antitrust Law, and was recognized in the American Association of Law School’s Hurricane Katrina Honor Roll for his volunteer work in New Orleans, Louisiana.

Publications

  • Contributor, Antitrust Law Developments (8th ed.)
  • Contributor, 2017 Annual Review of Antitrust Law Developments
  • Antitrust Post-Mortem of the Health Insurance Merger Decisions, American Health Lawyers Association
  • Benchmarking and Information Exchange: A Survey of U.S. Antitrust Laws, ABA Section of Antitrust Law, Spring Meeting 2017
  • Contributing Editor, Health Care Antitrust Week-In-Review, ABA Section of Antitrust Law, Health Care and Pharmaceuticals Committee
  • Contributor, Recent Developments, ABA Section of Antitrust Law, Health Care and Pharmaceuticals Committee Newsletter
  • Avoiding Failure: Applying Decision Theory to the Eminent Domain Jurisprudence, 20 Fed. Cir. B.J. 443 (2011)
Full Bio

Credentials

J.D., George Washington University Law School, with honors

B.A., Johns Hopkins University

District of Columbia

Maryland

U.S. Court of Appeals for the Federal Circuit

U.S. Court of International Trade

U.S. District Court for the Eastern District of Michigan

Matters

Counseled health system in joint operating agreement with a complementary health system in an antitrust investigation.

Advised pharmaceutical company on antitrust implications of pricing policy.

Successfully represented generic pharmaceuticals manufacturer in price-fixing cartel multidistrict litigation (In re Generic Pharmaceuticals Pricing Antitrust Litigation).

See more
Icon close

Close

Matters

Counseled health system in joint operating agreement with a complementary health system in an antitrust investigation.

Advised pharmaceutical company on antitrust implications of pricing policy.

Successfully represented generic pharmaceuticals manufacturer in price-fixing cartel multidistrict litigation (In re Generic Pharmaceuticals Pricing Antitrust Litigation).

Successfully represented two Japanese automobile parts manufacturers in price-fixing cartel actions and government investigations spanning multiple jurisdictions (In re Automotive Parts Antitrust Litigation).

Counseled medical device manufacturer on antitrust issues related to development of product distribution policy.

Second-chaired jury trial, obtaining defense verdict for corporation in civil action involving fraud and misrepresentation claims.

Insights

Article · Source: Lexis Practice Advisor

March 5, 2019
Sherman Act Section 1 Fundamentals

Article · Source: The Antitrust Source

December 21, 2017
A Call for Greater Consistency in the Failing Firm Defense

View all

Matters

Counseled health system in joint operating agreement with a complementary health system in an antitrust investigation.

Advised pharmaceutical company on antitrust implications of pricing policy.

Successfully represented generic pharmaceuticals manufacturer in price-fixing cartel multidistrict litigation (In re Generic Pharmaceuticals Pricing Antitrust Litigation).

See more
Icon close

Close

Matters

Counseled health system in joint operating agreement with a complementary health system in an antitrust investigation.

Advised pharmaceutical company on antitrust implications of pricing policy.

Successfully represented generic pharmaceuticals manufacturer in price-fixing cartel multidistrict litigation (In re Generic Pharmaceuticals Pricing Antitrust Litigation).

Successfully represented two Japanese automobile parts manufacturers in price-fixing cartel actions and government investigations spanning multiple jurisdictions (In re Automotive Parts Antitrust Litigation).

Counseled medical device manufacturer on antitrust issues related to development of product distribution policy.

Second-chaired jury trial, obtaining defense verdict for corporation in civil action involving fraud and misrepresentation claims.

Insights

Article · Source: Lexis Practice Advisor

March 5, 2019
Sherman Act Section 1 Fundamentals

Article · Source: The Antitrust Source

December 21, 2017
A Call for Greater Consistency in the Failing Firm Defense

View all

Credentials

J.D., George Washington University Law School, with honors

B.A., Johns Hopkins University

District of Columbia

Maryland

U.S. Court of Appeals for the Federal Circuit

U.S. Court of International Trade

U.S. District Court for the Eastern District of Michigan